Founder of Medicines for All Institute’s Vision: Produce Medications More Efficiently to Expand Global AccessMay 19, 20201 min read
B. Frank Gupton, Ph.D.
A former process development executive in the pharmaceutical industry, B. Frank Gupton, Ph.D., was coaxed out of retirement to teach in the Department of Chemical and Life Science Engineering at Virginia Commonwealth University.
Gupton, whose research focuses on improving health care by making pharmaceutical production cleaner and more cost-effective, is founder and CEO of the Medicines for All Institute (M4ALL), based in the VCU College of Engineering. The institute began with a simple idea: expand global access to lifesaving medications by producing them more efficiently.
The institute’s team of chemical engineers and chemists demonstrated compelling results with its first target, the anti-HIV/AIDS drug nevirapine. As the researchers continue to work on additional therapies for HIV/AIDS treatment and other diseases, M4ALL is now working with a manufacturer in South Africa and partnering with the government of Ivory Coast to bring their advances to the places they are most needed.
VCU Engineering’s experts are available to speak about how M4ALL is transforming pharmaceutical engineering and improving access to medicines around the world.
Gupton is the Floyd D. Gottwald Junior Chair in Pharmaceutical Engineering, professor and chair of the Department of Chemical and Life Science Engineering. An award-winning researcher and National Academy of Inventors Fellow with multiple patents, he is an expert in his field. Simply click on his icon to arrange an interview.
B. Frank Gupton, Ph.D. Floyd D. Gottwald Junior Chair in Pharmaceutical Engineering; Chair, Professor, Department of Chemical and Life Science Engineering
Professor Gupton's research is focused on the development of new technologies that will streamline organic synthesis